BEIJING: China’s National Health Commission says investigators have begun recalling defective vaccines produced by a Chinese drugmaker from domestic and overseas markets.
Investigators say they found Changchun Changsheng Life Sciences Ltd. had blended expired fluids in its vaccines and falsified records from as early as April 2014.
The names of the overseas countries involved were not given, but the recall indicated the scandal gripping China may have spread to foreign markets, dealing a potentially heavy blow to the reputation of China’s massive pharmaceutical industry.
China’s National Health Commission announced the recall in a statement Tuesday but did not immediately respond to a fax Wednesday seeking comment.
Regulators ordered a production halt last month, but public anger soared after leaked documents showed regulators had found inconsistencies in 2017 but failed to act.
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at email@example.com Contact no. 011-43720751